Terms: = Endocrine gland cancer AND HOXD11, ENSG00000128713, 3237
15 results:
1. Association of guideline-concordant care with survival, health care utilization, and costs among older women with advanced epithelial ovarian cancer.
Kamat S; Brown BR; Hume A; Vyas A
Am J Manag Care; 2023 Oct; 29(10):e292-e298. PubMed ID: 37870550
[TBL] [Abstract] [Full Text] [Related]
2. Incidental nonfunctioning pancreatic neuroendocrine tumors: Contrast enhanced ultrasound features in diagnosis1.
Yang D; Wang D; Qiu Y; Tian X; Zuo D; Dong Y; Lou W; Wang W
Clin Hemorheol Microcirc; 2022; 80(4):343-352. PubMed ID: 34602462
[TBL] [Abstract] [Full Text] [Related]
3. CT-diagnosed extra-pancreatic extension of pancreatic ductal adenocarcinoma is a more reliable prognostic factor for survival than pathology-diagnosed extension.
Toshima F; Inoue D; Yoshida K; Izumozaki A; Yoneda N; Minehiro K; Gabata T
Eur Radiol; 2022 Jan; 32(1):22-33. PubMed ID: 34263360
[TBL] [Abstract] [Full Text] [Related]
4. The fetal outcomes after neoadjuvant platinum and paclitaxel chemotherapy during pregnancy: analysis of three cases and review of the literature.
Wang M; Yin Z; Miao J; Wu Y
Arch Gynecol Obstet; 2022 Jan; 305(1):49-54. PubMed ID: 34115181
[TBL] [Abstract] [Full Text] [Related]
5. Pituitary adenoma with posterior area invasion of cavernous sinus: surgical anatomy, approach, and outcomes.
Wu X; Xie SH; Tang B; Yang YQ; Yang L; Ding H; Bao YY; Lan SH; Zhou L; Hong T
Neurosurg Rev; 2021 Aug; 44(4):2229-2237. PubMed ID: 33006012
[TBL] [Abstract] [Full Text] [Related]
6. Overnight/first-morning urine free metanephrines and methoxytyramine for diagnosis of pheochromocytoma and paraganglioma: is this an option?
Peitzsch M; Kaden D; Pamporaki C; Langton K; Constantinescu G; Conrad C; Fliedner S; Sinnott RO; Prejbisz A; Därr R; Lenders JWM; Bursztyn M; Eisenhofer G
Eur J Endocrinol; 2020 May; 182(5):499-509. PubMed ID: 32187575
[TBL] [Abstract] [Full Text] [Related]
7. Characterization of adrenal lesions at chemical-shift MRI: a direct intraindividual comparison of in- and opposed-phase imaging at 1.5 T and 3 T.
Ream JM; Gaing B; Mussi TC; Rosenkrantz AB
AJR Am J Roentgenol; 2015 Mar; 204(3):536-41. PubMed ID: 25714282
[TBL] [Abstract] [Full Text] [Related]
8. A Phase II trial of axitinib in patients with various histologic subtypes of advanced thyroid cancer: long-term outcomes and pharmacokinetic/pharmacodynamic analyses.
Cohen EE; Tortorici M; Kim S; Ingrosso A; Pithavala YK; Bycott P
Cancer Chemother Pharmacol; 2014 Dec; 74(6):1261-70. PubMed ID: 25315258
[TBL] [Abstract] [Full Text] [Related]
9. Assessment of combination of contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography for evaluation of ovarian masses.
Tsuboyama T; Tatsumi M; Onishi H; Nakamoto A; Kim T; Hori M; Sakane M; Hori Y; Morii E; Hatazawa J; Tomiyama N
Invest Radiol; 2014 Aug; 49(8):524-31. PubMed ID: 24637584
[TBL] [Abstract] [Full Text] [Related]
10. Lymph nodes metastasis and recurrences justify an aggressive treatment of gastrinoma.
Giovinazzo F; Butturini G; Monsellato D; Malleo G; Marchegiani G; Bassi C
Updates Surg; 2013 Mar; 65(1):19-24. PubMed ID: 23417896
[TBL] [Abstract] [Full Text] [Related]
11. Identification of PRTFDC1 silencing and aberrant promoter methylation of GPR150, ITGA8 and hoxd11 in ovarian cancers.
Cai LY; Abe M; Izumi S; Imura M; Yasugi T; Ushijima T
Life Sci; 2007 Mar; 80(16):1458-65. PubMed ID: 17303177
[TBL] [Abstract] [Full Text] [Related]
12. Differentiation between malignant and benign ovarian tumors by magnetic resonance imaging.
Chen M; Wang WC; Zhou C; Zhou NN; Cai K; Yang ZH; Zhao WF; Li SY; Li GZ
Chin Med Sci J; 2006 Dec; 21(4):270-5. PubMed ID: 17249204
[TBL] [Abstract] [Full Text] [Related]
13. Validation of somatostatin receptor scintigraphy in the localization of neuroendocrine tumors.
Lamberts SW; Reubi JC; Krenning EP
Acta Oncol; 1993; 32(2):167-70. PubMed ID: 8391830
[TBL] [Abstract] [Full Text] [Related]
14. [The assessment of clinical usefulness of 131I-MIBG scintigraphy for localization of tumors of sympathetic and adrenomedullary origin--a report of multicenter phase III clinical trials].
Sasaki Y; Kubo A; Kusakabe K; Masaki H; Endo K; Yamashita M; Nakajo M; Kaneko M
Kaku Igaku; 1992 Sep; 29(9):1083-98. PubMed ID: 1360549
[TBL] [Abstract] [Full Text] [Related]
15. Vinblastine (VLB), bleomycin (BLEO), cis-diamminedichloroplatinum (DDP) in disseminated extragonadal germ cell tumors. A Southwest Oncology Group Study.
Feun LG; Samson MK; Stephens RL
Cancer; 1980 May; 45(10):2543-9. PubMed ID: 6155194
[TBL] [Abstract] [Full Text] [Related]
